Aspen Neuroscience falls 6% to 52-week low

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Aspen Neuroscience (ASPE.US) fell more than 6% during regular trading to $11.51, hitting a 52-week low.

The Nasdaq Composite is down 3.28% over the past five sessions.

The company's amended charter took effect on Nov. 2, 2026, coinciding with the closing of its initial public offering. Aspen Neuroscience issued 9.375 million shares of common stock at $15 per share, raising gross proceeds of approximately $140.6 million before underwriting discounts and expenses.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.